Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

78results about How to "Lower intracranial pressure" patented technology

Injection of mannite and glycerol and preparation method thereof

The invention discloses injection of mannite and glycerol, which contains mannite, glycerol and water for injection. Furthermore, the invention also discloses a method for preparing the injection, which comprises the following steps: taking the mannite and the glycerol, dissolving into the water for injection, filtering and filling. The injection of the mannite and the glycerol is clinically used for treating cerebrovascular diseases, brain trauma, cerebral tumors, intracranial inflammation and the diseases of acute and chronic intracranial hypertension, hydrocephalus and the like caused by other reasons. The injection of the mannite and the glycerol has the functions of lowering the intracranial pressure quickly and eliminating the hydrocephalus and can also avoid death because of acute renal failure caused by the injury of the kidney; the injection of the mannite and the glycerol suppresses the apoptosis of neural cells and achieves the function of protecting the brain; the function of lowering the intracranial pressure is stable and has long retention time; crystals occurring because of the change of the air temperature or in the processes of storage and transportation are eliminated; and the glycerol is used as a caloric agent and can improve and recover the energy metabolism of the important viscera of the heart, the brain, the kidney and the like during oxygen deficiency. The injection of the mannite and the glycerol is a very effective, stable and safe medicine for promoting urination and removing water clinically.
Owner:北京圣方达隆医药科技发展有限责任公司 +2

Chinese materia medica preparation for treating hydrocephalus and preparation method thereof

The invention relates to a Chinese materia medica preparation for treating hydrocephalus, which is prepared by the bulk drugs with weight as follows: 300-340g of cornus officinalis, 160-200g of deerhorn glue, 300-340g of twotooth achyranthes root, 390-410g of yam, 390-410g of Indian buead, 390-410g of grifola, 300-340g of oriental waterplantain rhizome, 300-340g of tree peony bark, 300-340g of motherwort fruit and 160-200g of radix astragali. The preparation method comprises the following steps: (1) weighing other drugs except the deerhorn glue according to the prescribed doses, adding 6-8 times of water to the drugs and decocting the drugs for three times, with 1.5-2h every time, combining and filtering decoction; (2) taking prescribed doses of the deerhorn glue and grinding the deerhorn glue into coarse powder, adding the powder into the decoction in the step (1) and melting the mixture by heat, filtering the mixture, concentrating filtrate into extract with relative density of 1.33-1.38, adding powdered sugar and dextrin to the extract based on the weight ratio of 1:2:1 among the extract, powdered sugar and dextrin, and adding proper amount of ethanol to prepare soft materials, pelletizing and drying the soft materials, and obtaining the Chinese materia medica preparation after pelletizing. The Chinese materia medica preparation has evident effect, no obvious toxic side effect, and simple preparation process, and is suitable for infantile hydrocephalus, communicating hydrocephalus, normal-pressure hydrocephalus and intracranial pressure reduction, etc.
Owner:李桂华

Sleep-aiding control method and device

The invention provides a sleep-aiding control method and device, and the method comprises the steps: a relaxing stage: controlling an electric bed to execute a human body relaxing mode so as to relax and massage the muscles of a human body; and in the sleep-aiding stage, controlling the electric bed to execute a body position sleep-aiding mode so as to promote intracranial venous return of the human body. According to the sleep-aiding control method and device provided by the invention, the human body is moderately stretched and vibratively massaged in a relaxing stage, tense muscles of the human body are relieved, muscle fatigue is eliminated, the comfort of the human body is improved, and the human body enters a deep relaxing state, and then enters a sleep-aiding stage, so that the head of the human body is raised, extravasated blood in the lung is reduced, and the oxygen inhalation amount is increased; in addition, intracranial pressure is relieved, intracranial venous return is promoted, blood can circulate in the brain as soon as possible, a human body is helped to enter the sleep stage quickly, fatigue can be eliminated, blood and oxygen can be promoted to enter the brain as soon as possible, and the human body can enter the sleep state more quickly through the two stages.
Owner:KEESON TECH CORP LTD

Head and neck lymphatic drainage regulation and control instrument and use method thereof

The invention discloses a head and neck lymph drainage regulation and control instrument and a use method thereof, and relates to the field of clinical neurology (neurosurgery and neurology). The head and neck lymph drainage regulation and control instrument comprises a drainage pump and a drainage head sleeve. The drainage head sleeve comprises a head beam, a locking knob, pressing earmuffs, an inflation bandage and an air pipe. An air bag structure is used for replacing human hands for massage, and the drainage speed of a lymphatic system to brain metabolites is increased by pressing lymphatic tissues in front of ears, behind ears and at the lower jaw, so that the purposes of reducing intracranial pressure and discharging toxic macromolecular proteins generated by metabolism of the brain tissues out of the cranium are achieved. When the physical method is used for massaging the head lymph of a patient, the discharge of intracranial harmful substances can be accelerated, the intracranial pressure of the patient can be reduced, the opportunity that the patient is subjected to surgical treatment can be reduced or avoided, the accumulation of intracranial harmful metabolites of the craniotomy patient can be reduced, the postoperative infection risk can be reduced or avoided, the discharge of head metabolic toxic macromolecular proteins can be accelerated, and the memory, sleep and neurocognition can be improved.
Owner:上海浩聚医疗科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products